Influence of repeated plaque visualization on cardiovascular risk reduction after 3 years : a randomized controlled trial

dc.contributor.authorWhitmore, Kristyn
dc.contributor.authorZhou, Zhen
dc.contributor.authorRyan, Jacqueline D. M.
dc.contributor.authorMagnussen, Costan G.
dc.contributor.authorCarrington, Melinda J.
dc.contributor.authorMarwick, Thomas H.
dc.contributor.authorCAUGHT CAD investigators
dc.contributor.organizationfi=sydäntutkimuskeskus|en=Cardiovascular Medicine (CAPC)|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organizationfi=väestötutkimuskeskus|en=Centre for Population Health Research (POP Centre)|
dc.contributor.organization-code1.2.246.10.2458963.20.35734063924
dc.contributor.organization-code1.2.246.10.2458963.20.42471027641
dc.converis.publication-id484866472
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/484866472
dc.date.accessioned2025-08-28T03:34:37Z
dc.date.available2025-08-28T03:34:37Z
dc.description.abstract<p><strong>Aims</strong><br></p><p>Helping people to understand their cardiovascular (CV) risk can influence the choices they make for risk reduction, including medication adherence and lifestyle modification. This study sought whether repeated visualization of coronary artery calcium (CAC) images was effective in sustaining long-term risk control in primary prevention, independent of a risk reduction programme.<br></p><p><strong>Methods and results</strong><br></p><p>Asymptomatic, statin-na & iuml;ve participants, 40-70 years, with a family history of premature coronary artery disease and a CAC score from 1-400 were randomized to a nurse-led CV risk reduction programme or standard care with bi-annual reviews. Only the intervention group (220 of 449 participants) visualized their CAC image (with repeat exposure in the first 3 months) and were initiated on statin therapy. The primary outcome was change in Framingham Risk Score (FRS) at 36 months, and the impact of CAC image recall on CV risk was assessed. The reduction in FRS (difference in differences (DID) -3.4% [95% CI: -4.4% to -2.4%], P <= 0.001 and low density lipoprotein cholesterol -1.2 mmol/L [95% CI: -1.4 to -1.0], P <= 0.001) over 36 months was greater in the intervention than the control group. Within the intervention group, sustained recall of CAC images at 24 months was associated with lower systolic blood pressure (DID -4.3 mmHg [95% CI: -7.7 to -0.9], P = 0.01) and waist circumference (DID -2.0 cm [95% CI: -3.9 to -0.1], P = 0.03) at 36 months compared to unsustained recall.<br></p><p><strong>Conclusion </strong><br></p><p><strong></strong>A nurse-led programme, combining personalized patient visualization of CAC imaging with statin therapy, is beneficial for improving CV risk. Recalling the presentation of CAC images through repeated visual exposure may influence risk reduction.<br></p><p><strong>Registration </strong><br></p><p><strong></strong>Australia New Zealand Clinical Trials Registry: ACTRN12614001294640<br></p><p><strong>Lay summary </strong><br></p><p></p><ul><li><strong>​​​​​​​</strong>This trial sought to determine whether visualization of coronary artery calcium (CAC) images influences behaviour change and cardiovascular risk reduction within a structured nurse-led programme vs. standard care.<br></li><li> Intervention participants visualized their personalized CAC images within the first three months and commenced statin therapy. Control participants were blinded to their CAC images and were not provided statin therapy. Intervention participants had a greater absolute reduction in the Framingham Risk Score (difference in differences -3.4% [95% CI: -4.4% to -2.4%], P <= 0.001) compared to controls. <br></li><li>Those with sustained recollection of their CAC images within the intervention group also had greater reductions in systolic blood pressure and waist circumference.</li></ul><p></p>
dc.format.pagerange596
dc.format.pagerange605
dc.identifier.eissn2047-4881
dc.identifier.jour-issn2047-4873
dc.identifier.olddbid210848
dc.identifier.oldhandle10024/193875
dc.identifier.urihttps://www.utupub.fi/handle/11111/56604
dc.identifier.urlhttps://doi.org/10.1093/eurjpc/zwae026
dc.identifier.urnURN:NBN:fi-fe2025082786752
dc.language.isoen
dc.okm.affiliatedauthorMagnussen, Costan
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherOXFORD UNIV PRESS
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.publisher.placeOXFORD
dc.relation.doi10.1093/eurjpc/zwae026
dc.relation.ispartofjournalEuropean Journal of Preventive Cardiology
dc.relation.issue7
dc.relation.volume32
dc.source.identifierhttps://www.utupub.fi/handle/10024/193875
dc.titleInfluence of repeated plaque visualization on cardiovascular risk reduction after 3 years : a randomized controlled trial
dc.year.issued2025

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
zwae026.pdf
Size:
725.52 KB
Format:
Adobe Portable Document Format